ID: ALA4218315

Max Phase: Preclinical

Molecular Formula: C34H47Cl2N5O7S

Molecular Weight: 740.75

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CN(C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO)C(=O)NCCCCc1cc(Cl)c(CN2CSC[C@H]2C(=O)N2CCN(C3CC3)c3ccccc32)cc1Cl

Standard InChI:  InChI=1S/C34H47Cl2N5O7S/c1-38(17-29(43)31(45)32(46)30(44)18-42)34(48)37-11-5-4-6-21-14-25(36)22(15-24(21)35)16-39-20-49-19-28(39)33(47)41-13-12-40(23-9-10-23)26-7-2-3-8-27(26)41/h2-3,7-8,14-15,23,28-32,42-46H,4-6,9-13,16-20H2,1H3,(H,37,48)/t28-,29-,30+,31+,32+/m0/s1

Standard InChI Key:  LYYFIIIMQLYSPV-PCYHVKPNSA-N

Associated Targets(Human)

G-protein coupled bile acid receptor 1 1723 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

G-protein coupled bile acid receptor 1 577 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Mus musculus 284745 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 740.75Molecular Weight (Monoisotopic): 739.2573AlogP: 2.28#Rotatable Bonds: 15
Polar Surface Area: 160.28Molecular Species: NEUTRALHBA: 10HBD: 6
#RO5 Violations: 2HBA (Lipinski): 12HBD (Lipinski): 6#RO5 Violations (Lipinski): 3
CX Acidic pKa: 12.64CX Basic pKa: 3.65CX LogP: 1.80CX LogD: 1.80
Aromatic Rings: 2Heavy Atoms: 49QED Weighted: 0.15Np Likeness Score: -0.70

References

1. Chen T, Reich NW, Bell N, Finn PD, Rodriguez D, Kohler J, Kozuka K, He L, Spencer AG, Charmot D, Navre M, Carreras CW, Koo-McCoy S, Tabora J, Caldwell JS, Jacobs JW, Lewis JG..  (2018)  Design of Gut-Restricted Thiazolidine Agonists of G Protein-Coupled Bile Acid Receptor 1 (GPBAR1, TGR5).,  61  (17): [PMID:30141927] [10.1021/acs.jmedchem.8b00308]

Source